The significant differences in business models between contract manufacturing organizations (CMOs) and biotherapeutic developers translates to very divergent reasons for their increased use of disposable, single-use biomanufacturing devices, ...
Tuesday, November 01, 2011
Hiring problems, and finding experienced technical and production staff have biomanufacturers worried about production bottlenecks this year.